Also found in: Medical, Wikipedia.
ADMEAbsorption, Distribution, Metabolism, and Excretion
ADMEAssociation of Destination Management Executives
ADMEActive Duty Medical Extension
ADMEAdvertising in a Digital Media Environment (Belgium)
ADMEAssociation for Doctor of Ministry Education
ADMEAssociate Director of Medical Education (various universities)
References in periodicals archive ?
Certain expert contract research organizations (CROs) have a wealth of ADME experience and expertise, and can adapt and tailor their services to meet the client's needs and, as these can be called upon as required, can be an effective way to control costs.
Harder TC, Kenter M, Appel MJ, Roelke-Parker ME, Barrett T, Osterhaus ADME.
2 Optimal ADME Properties for Clinical Candidate and Investigational New Drug (IND) Package
The newly expanded ADME Suite adds to Celerion's capabilities to manage all aspects of human radiolabeled ADME studies from synthesis and formulation of an appropriate radiolabeled drug through dosimetry assessment and clinical conduct to final isolation, identification and quantification of metabolites in the samples collected.
Cyprotex is the world's largest contract research organisation (CRO) specialising in ADME Tox, which is the analysis of the Absorption, Distribution, Metabolism, Excretion and Toxicity properties of potential drugs, cosmetics, and agrochemicals.
We are very pleased to be working closely with RainDance to deliver this innovative and first-of-its-kind ADME sequencing service," said Ardy Arianpour, Vice President of Business Development at Ambry Genetics.
We look forward to working with O2h and of taking advantage of its expanding ADME portfolio.
Fragment-Based Drug Design: Considerations for Good ADME Properties (Haitao Ji).
Identifying potential liabilities at an early stage in drug discovery decreases the likelihood of late-stage failures, and promises to produce the same magnitude of drug development efficiency improvements that preclinical ADME has provided.
Current ADME research products are primarily limited to genotyping common alleles, and therefore lack the sensitivity, breadth of genomic coverage and ability to identify previously unknown variants that are important to drive scientific discovery and routine use.
INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations I-1 Disclaimers I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-2 Product Definitions and Scope of Study I-3 ADME-Tox - An Introduction I-3 Toxicology Testing I-3 ADME Testing I-3
The initial offering via Cloe(R) Gateway is a new enhanced version of our proprietary predictive software, Cloe(R) PK, which predicts whole body pharmacokinetics from simple in vitro ADME and physicochemical properties.